Actinium Pharmaceuticals Inc (ATNM)
Healthcare
Biotechnology
0.84 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Actinium Pharmaceuticals Inc (ATNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14 | -19 | -21 | -22 | -21 | -21 | -22 | -21 | 8.6 | -47 | -33 | -25 | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.4 | 0.5 | 0.7 | 0.8 | 0.8 | 0.8 | |
| 6.3 | 7.1 | 4.3 | 3.5 | 1.8 | 1.3 | 1.3 | 1.7 | 2.8 | 3.8 | 5.3 | 9.2 | |
| 6.3 | 3.2 | 1.8 | 3.2 | 1.8 | 1.3 | 1.3 | 1.7 | 2.8 | – | – | – | |
| 1.8 | -0.8 | 1.7 | 1.8 | 1.2 | -1.3 | -1.1 | 1.7 | 38 | -3.1 | -0.9 | -0.7 | |
| 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.3 | 0.1 | 0.4 | 0.2 | 0.0 | 0.1 | |
| -0.2 | 0.0 | -0.1 | -0.4 | -0.1 | -0.1 | -0.3 | -0.1 | -0.4 | -0.2 | 0.0 | -0.1 | |
| – | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | |
| 15 | 38 | 16 | 19 | 17 | 0.0 | 0.0 | 35 | – | – | – | -0.2 | |
| -0.2 | -0.3 | -0.3 | -0.3 | 0.0 | -0.2 | -0.5 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 16 | 38 | 16 | 19 | 17 | 17 | 76 | 35 | 23 | 15 | 29 | -0.2 | |
| 1.2 | 19 | -5.1 | -3.1 | -3.7 | -4.4 | 54 | 14 | 31 | -33 | -3.8 | -25 | |
| -15 | -19 | -21 | -22 | -21 | -22 | -22 | -21 | 8.3 | -47 | -33 | -25 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.